BeyondSpring Inc. (BYSI) vs Quantum Biopharma Ltd. (QNTM)

BeyondSpring Inc. and Quantum Biopharma Ltd. are both Biotechnology companies. BeyondSpring Inc. and Quantum Biopharma Ltd. are of similar size ($30.9M and $29.8M). Across the 10 metrics below, BeyondSpring Inc. leads on 7 and Quantum Biopharma Ltd. on 3.

Valuation

Metric BYSI QNTM Biotechnology median
P/E n/m n/m 7.88
P/S 23.74 110.47 11.47
P/B n/m 4.20 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 21.16 68.43 10.73
Earnings yield (33.71%) (142.60%) (28.84%)
Free cash flow yield (52.37%) (35.37%) (23.03%)

Profitability

Metric BYSI QNTM Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 24.96% (618.06%) (57.72%)
Return on assets (29.29%) (169.48%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BYSI QNTM Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 96.30% 37.50% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BYSI QNTM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.70 1.20 4.73
Net debt to EBITDA 1.42 0.31 0.96

Dividend

Metric BYSI QNTM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BYSI QNTM Biotechnology median
Market cap 29.81m 30.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack